Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 821 to 830 of 2013

TitleReference numberPublishedLast updated
Liraglutide for managing overweight and obesityTA664
Upadacitinib for treating severe rheumatoid arthritisTA665
Zio XT for detecting cardiac arrhythmiasHTG562
Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancerTA660
Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinomaTA661
Durvalumab in combination for untreated extensive-stage small-cell lung cancer (terminated appraisal)TA662
Acute coronary syndromesNG185
Drug-eluting stents for the treatment of coronary artery diseaseTA152
Galcanezumab for preventing migraineTA659
Guidance on the use of coronary artery stentsTA71

Results per page

  1. 10
  2. 25
  3. 50
  4. All